Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001520138-24-000421
Filing Date
2024-11-13
Accepted
2024-11-13 15:36:53
Documents
77
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q esgh-20240930_10q.htm   iXBRL 10-Q 622092
2 EX-31.1 esgh-20240930_ex31z1.htm EX-31.1 13083
3 EX-32.1 esgh-20240930_ex32z1.htm EX-32.1 5116
4 GRAPHIC image_01.jpg GRAPHIC 51078
  Complete submission text file 0001520138-24-000421.txt   4442299

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE esgh-20240930.xsd EX-101.SCH 38621
6 XBRL CALCULATION FILE esgh-20240930_cal.xml EX-101.CAL 60723
7 XBRL DEFINITION FILE esgh-20240930_def.xml EX-101.DEF 99102
8 XBRL LABEL FILE esgh-20240930_lab.xml EX-101.LAB 300919
9 XBRL PRESENTATION FILE esgh-20240930_pre.xml EX-101.PRE 247149
79 EXTRACTED XBRL INSTANCE DOCUMENT esgh-20240930_10q_htm.xml XML 626500
Mailing Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348
Business Address 523 SCHOOL HOUSE RD KENNETT SQUARE PA 19348 267-467-5871
ESG Inc. (Filer) CIK: 0001883835 (see all company filings)

EIN.: 871918342 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56532 | Film No.: 241453668
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)